Vimarsana
Biggest News Aggregation in the World

Page 20 - Quantitative Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quantitative Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quantitative Research Today - Breaking & Trending Today

IPO lock-in expiry: Shares worth Rs 1.47 lakh crore to enter market between April and July - Vimarsana News

IPO lock-in expiry: Shares worth Rs 1.47 lakh crore to enter market between April and July

The lock-in period of Global Surfaces, Sai Silks (Kalamandir), JSW Infrastructure, Platinum Industries and Exicom Telesystems opened on Monday with the stocks of all five companies ending the session in green

FIIs' stock futures positions near all-time high, highly leveraged on long side - Vimarsana News

FIIs' stock futures positions near all-time high, highly leveraged on long side

In single stock futures, FIIs net long positions stood at 4.48 lakh contracts vs 78,000 at the start of March series.

NSE to rejig Nifty indices on March 28: Shriram Finance, HDFC Bank to see highest inflows - Vimarsana News

NSE to rejig Nifty indices on March 28: Shriram Finance, HDFC Bank to see highest inflows

The semi-annual rebalancing of the indices is scheduled for March 28; Shriram Finance and HDFC Bank are likely to receive inflows of up to $188 mn and $94 mn

NSE to rejig Nifty indices: Here are stocks likely to see highest inflows, outflows - Vimarsana News

NSE to rejig Nifty indices: Here are stocks likely to see highest inflows, outflows

Shriram Finance is expected to receive highest inflows after being added to Nifty 50

Source: theweek.in
mankind pharma shares: Mankind Pharma stock falls 3% as PE investors likely sell 1.3 crore shares - Vimarsana News

mankind pharma shares: Mankind Pharma stock falls 3% as PE investors likely sell 1.3 crore shares

PE firm ChrysCapital's affiliate entity Beige Ltd was reported to have issued a term sheet via its broker to sell up to 1.16 crore shares of Mankind Pharma at a price range of Rs 2,103.21 to Rs 2,214 per share.